Common misconceptions

Common mistake
Wrong: Dobutamine increases cardiac output by shifting the operating point rightward along the same Frank-Starling curve (increased preload).
Right: Dobutamine increases contractility, shifting the entire Frank-Starling curve upward so that greater stroke volume is generated at the same EDV.
Dobutamine is a positive inotrope — it increases contractility, which means the ventricle is intrinsically stronger regardless of how much it's filled. This shifts the entire Starling curve upward: at the same EDV, you now get more stroke volume. Moving rightward along the same curve would mean the ventricle is simply filling more (increased preload), with no change in the muscle's intrinsic squeezing power. When you see dobutamine on a graph question, the operating point should jump to a higher curve, not slide along the original one.
Common mistake
Wrong: HFrEF shifts the Frank-Starling curve upward and to the left.
Right: HFrEF shifts the Frank-Starling curve downward and to the right, so the ventricle generates less stroke volume at any given EDV.
In HFrEF, the myocardium is intrinsically weakened — it generates less force for any given stretch. This pushes the Starling curve downward and to the right: you need more EDV just to get the same (or still reduced) stroke volume. An upward-leftward shift would imply a stronger heart, which is the opposite of what's happening in systolic failure. The key mental image is a flattened, depressed curve sitting below the normal one — the heart is doing less with more.
Common mistake
Wrong: The Frank-Starling mechanism works because stretching sarcomeres increases the number of myosin heads.
Right: Sarcomere stretch increases myofilament Ca2+ sensitivity and optimizes actin-myosin overlap, generating greater force without changing the number of myosin heads.
The Frank-Starling effect does not work by generating more myosin heads — that number is fixed. What changes with sarcomere stretch is twofold: first, the geometric overlap between actin and myosin filaments moves closer to the optimal range for cross-bridge cycling; second, and more importantly for Step 1, stretched sarcomeres increase the sensitivity of troponin C to calcium, so the same amount of Ca2+ triggers stronger force development. The result is more contractile force from the same calcium transient — no new proteins needed.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Define the Frank-Starling relationship: how increased ventricular end-diastolic volume leads to increased stroke volume, and why this is a built-in cardiac property.
  2. Explain the sarcomere-level mechanism: how stretching myofilaments optimizes actin-myosin overlap and increases myofilament sensitivity to calcium — without adding new myosin heads.
  3. Distinguish between a shift along the Frank-Starling curve (caused by a preload change) versus an upward or downward shift of the entire curve (caused by a change in contractility — e.g., dobutamine shifts up, negative inotropes shift down).
  4. Describe how HFrEF alters the Frank-Starling curve: the curve shifts downward and to the right, meaning the failing ventricle produces less stroke volume at any given EDV compared to a normal ventricle.

Can you avoid these mistakes?

A patient receives IV fluids, increasing their end-diastolic volume from 120 mL to 150 mL. Stroke volume increases from 70 mL to 85 mL. On a Frank-Starling graph, how does this change appear — as a shift of the curve or a movement along the existing curve? What would have to be different for the curve itself to shift?
At the sarcomere level, what are the two mechanisms that explain why greater stretch produces greater contractile force? Why is 'more myosin heads' not the correct answer?
A patient with HFrEF has an EDV of 200 mL but a stroke volume of only 55 mL. A normal heart at EDV 120 mL generates 70 mL. On a Starling curve diagram, which direction is the HFrEF curve shifted relative to normal, and what does that shift tell you about intrinsic contractility?
Dobutamine is started in a patient with cardiogenic shock. Their EDV stays roughly the same, but stroke volume increases substantially. How do you represent this on a Frank-Starling curve, and how does this differ from what would happen if you had given IV fluids instead?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →